The Role of Integrins in Cancer and the Development of Anti-integrin Therapeutic Agents for Cancer Therapy

Overview

Journal Perspect Medicin Chem

Publisher Sage Publications

Specialty Chemistry

Date 2009 Sep 30

PMID 19787098

Citations 29

Authors

Xinjie Lu

Dong Lu

Mike Scully

Vijay Kakkar

Affiliations

Soon will be listed here.

Abstract

Integrins have been reported to mediate cell survival, proliferation, differentiation, and migration programs. For this reason, the past few years have seen an increased interest in the implications of integrin receptors in cancer biology and tumor cell aggression. This review considers the potential role of integrins in cancer and also addresses why integrins are present attractive targets for drug design. It discusses of the several properties of the integrin-based chemotherapeutic agents currently under consideration clinically and provides an insight into cancer drug development using integrin as a target.

Citing Articles

Potential association between COVID-19 and neurological disorders: analysis of common genes and therapeutics.

Chen W, Jiang S, Li C, Li S, Wang J, Xu R Front Neurol. 2024; 15:1417183.

PMID: 39469068 PMC: 11513677. DOI: 10.3389/fneur.2024.1417183.

The Role of αvβ3 Integrin in Cancer Therapy Resistance.

Pachane B, Selistre-de-Araujo H Biomedicines. 2024; 12(6).

PMID: 38927370 PMC: 11200931. DOI: 10.3390/biomedicines12061163.

ITGAV Promotes the Progression of Head and Neck Squamous Cell Carcinoma.

Xu L, Barrett J, Peng J, Li S, Messadi D, Hu S Curr Oncol. 2024; 31(3):1311-1322.

PMID: 38534932 PMC: 10969037. DOI: 10.3390/curroncol31030099.

Quantitative glycoproteomics analysis identifies novel FUT8 targets and signaling networks critical for breast cancer cell invasiveness.

Tu C, Li F, Li L, Yang R Breast Cancer Res. 2022; 24(1):21.

PMID: 35303925 PMC: 8932202. DOI: 10.1186/s13058-022-01513-3.

Enhancing Ra Treatment Efficacy by Anti-1 Integrin Targeting.

Paindelli C, Casarin S, Wang F, Diaz-Gomez L, Zhang J, Mikos A J Nucl Med. 2021; 63(7):1039-1045.

PMID: 34711616 PMC: 9258579. DOI: 10.2967/jnumed.121.262743.

References

Hallahan D, Qu S, Geng L, Cmelak A, Chakravarthy A, Martin W . Radiation-mediated control of drug delivery. Am J Clin Oncol. 2001; 24(5):473-80. DOI: 10.1097/00000421-200110000-00012. View

White D, Kurpios N, Zuo D, Hassell J, Blaess S, Mueller U . Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell. 2004; 6(2):159-70. DOI: 10.1016/j.ccr.2004.06.025. View

Pawar S, Demetriou M, Nagle R, Bowden G, Cress A . Integrin alpha6 cleavage: a novel modification to modulate cell migration. Exp Cell Res. 2007; 313(6):1080-9. PMC: 1905853. DOI: 10.1016/j.yexcr.2007.01.006. View

Baselga J, Tripathy D, Mendelsohn J, Baughman S, Benz C, Dantis L . Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J Clin Oncol. 1996; 14(3):737-44. DOI: 10.1200/JCO.1996.14.3.737. View

Zutter M, Santoro S, Staatz W, Tsung Y . Re-expression of the alpha 2 beta 1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc Natl Acad Sci U S A. 1995; 92(16):7411-5. PMC: 41349. DOI: 10.1073/pnas.92.16.7411. View

Miyata S, Koshikawa N, Yasumitsu H, Miyazaki K . Trypsin stimulates integrin alpha(5)beta(1)-dependent adhesion to fibronectin and proliferation of human gastric carcinoma cells through activation of proteinase-activated receptor-2. J Biol Chem. 2000; 275(7):4592-8. DOI: 10.1074/jbc.275.7.4592. View

Jackson T, Clark S, Berryman S, Burman A, Cambier S, Mu D . Integrin alphavbeta8 functions as a receptor for foot-and-mouth disease virus: role of the beta-chain cytodomain in integrin-mediated infection. J Virol. 2004; 78(9):4533-40. PMC: 387692. DOI: 10.1128/jvi.78.9.4533-4540.2004. View

Sheu J, Wu C, Chen Y, Hsiao G, Lin C . Mechanisms in the inhibition of neointimal hyperplasia with triflavin in a rat model of balloon angioplasty. J Lab Clin Med. 2001; 137(4):270-8. DOI: 10.1067/mlc.2001.114065. View

Galliher A, Schiemann W . Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells. Breast Cancer Res. 2006; 8(4):R42. PMC: 1779461. DOI: 10.1186/bcr1524. View

10.

Ziober B, Chen Y, Ramos D, Waleh N, Kramer R . Expression of the alpha7beta1 laminin receptor suppresses melanoma growth and metastatic potential. Cell Growth Differ. 1999; 10(7):479-90. View

11.

Kuwada S, Kuang J, Li X . Integrin alpha5/beta1 expression mediates HER-2 down-regulation in colon cancer cells. J Biol Chem. 2005; 280(19):19027-35. DOI: 10.1074/jbc.M410540200. View

12.

Marcinkiewicz C, Weinreb P, Calvete J, Kisiel D, Mousa S, Tuszynski G . Obtustatin: a potent selective inhibitor of alpha1beta1 integrin in vitro and angiogenesis in vivo. Cancer Res. 2003; 63(9):2020-3. View

13.

McCabe N, De S, Vasanji A, Brainard J, Byzova T . Prostate cancer specific integrin alphavbeta3 modulates bone metastatic growth and tissue remodeling. Oncogene. 2007; 26(42):6238-43. PMC: 2753215. DOI: 10.1038/sj.onc.1210429. View

14.

Heino J . The collagen receptor integrins have distinct ligand recognition and signaling functions. Matrix Biol. 2000; 19(4):319-23. DOI: 10.1016/s0945-053x(00)00076-7. View

15.

Gladson C, Hancock S, Arnold M, Faye-Petersen O, Castleberry R, Kelly D . Stage-specific expression of integrin alphaVbeta3 in neuroblastic tumors. Am J Pathol. 1996; 148(5):1423-34. PMC: 1861568. View

16.

Gettner S, Kenyon C, Reichardt L . Characterization of beta pat-3 heterodimers, a family of essential integrin receptors in C. elegans. J Cell Biol. 1995; 129(4):1127-41. PMC: 2120502. DOI: 10.1083/jcb.129.4.1127. View

17.

Sakai T, Zhang Q, Fassler R, Mosher D . Modulation of beta1A integrin functions by tyrosine residues in the beta1 cytoplasmic domain. J Cell Biol. 1998; 141(2):527-38. PMC: 2148458. DOI: 10.1083/jcb.141.2.527. View

18.

Li F, Redick S, Erickson H, Moy V . Force measurements of the alpha5beta1 integrin-fibronectin interaction. Biophys J. 2003; 84(2 Pt 1):1252-62. PMC: 1302701. DOI: 10.1016/S0006-3495(03)74940-6. View

19.

Hirsch E, Iglesias A, Potocnik A, Hartmann U, Fassler R . Impaired migration but not differentiation of haematopoietic stem cells in the absence of beta1 integrins. Nature. 1996; 380(6570):171-5. DOI: 10.1038/380171a0. View

20.

Maglott A, Bartik P, Cosgun S, Klotz P, Ronde P, Fuhrmann G . The small alpha5beta1 integrin antagonist, SJ749, reduces proliferation and clonogenicity of human astrocytoma cells. Cancer Res. 2006; 66(12):6002-7. DOI: 10.1158/0008-5472.CAN-05-4105. View